본문바로가기

Circulatory system/ Metabolic disease

메인페이지로 이동
Business
Life Science
ETC
혈액순환개선제
Ginexin-F Tab. 40,80
Category
OTC
Indication(s)·Usage
    • ① Peripheral arterial circulatory disorders (intermittent claudication)
    • ② Dizziness, tinnitus
    • ③ Organic brain syndrome with dementia symptoms such as tinnitus, headache, memory loss, concentration disorder, depression, and dizziness
Effective components
Ginexin-F Tab.: gingko biloba extract 40 mg
Ginexin-F Tab. 80 mg: gingko biloba extract 80 mg

Active ingredient(s) and Contents

  • Effective components

    • Ginexin-F Tab.: gingko biloba extract 40 mg
      Ginexin-F Tab. 80 mg: gingko biloba extract 80 mg

  • Other

    • Ginexin-F Tab., Ginexin-F Tab. 80 mg: Talc, Polyethylene Glycol 6000, Titanium Oxide, FD&C Blue No.1 Aluminum Lake, Anhydrous Dibasic Calcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Light Anhydrous Silicic Acid, Hypromellose 2910, Yellow No.203 Aluminum Lake

Dosage and administration

  • Adults
    ① peripheral arterial circulatory disorders, dizziness, tinnitus: Orally administer 40 mg of gingko biloba extract 3 times daily or 80 mg of gingko biloba extract twice daily.
    ② organic brain syndrome: Orally administer 40 to 80 mg of gingko biloba extract 3 times daily or 120 mg of gingko biloba extract twice daily.
    The dose may be adjusted depending on the patient’s age and symptoms.

Storage and handling

  • Airtight container, keep at room temperature (1~30°C)